about
Breast cancer patients' experiences within and outside the safety net.Perceived barriers to mammography among underserved women in a Breast Health Center Outreach Program.Contralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysisA method for achieving reciprocity of funding in community-based participatory research.Therapeutic management of intracystic papillary carcinoma of the breast: the roles of radiation and endocrine therapy.Patient and process factors associated with late-stage breast cancer diagnosis in Safety-Net patients: a pilot prospective study.Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely (®) InitiativeGeographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.Withdrawal of care in a potentially curable patient.The American Society of Breast Surgeons and Quality Payment Programs: Ranking, Defining, and Benchmarking More Than 1 Million Patient Quality Measure Encounters.Surgical Education and Health Care Reform: Defining the Role and Value of Trainees in an Evolving Medical Landscape.Body mass index mediates the prognostic significance of circulating tumor cells in inflammatory breast cancer.Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes.Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters.Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011.Molecular Genomic Testing for Breast Cancer: Utility for Surgeons.Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology DatabaseContralateral Prophylactic Mastectomy: Aligning Patient Preferences and Provider RecommendationsPostmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through CollaborationA Case-Control Study Examining Disparities in Clinical Trial Participation Among Breast Surgical Oncology PatientsNodal Response to Neoadjuvant Chemotherapy Predicts Receipt of Radiation Therapy After Breast Cancer DiagnosisPatient-reported outcomes in the Translational Breast Cancer Research ConsortiumThe impact of chemotherapy sequence on survival in node-positive invasive lobular carcinomaHiding in Plain SightFactors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon MembersNeoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular CarcinomaThe effect of treatment on patient-reported distress after breast cancer diagnosisExtent of axillary surgery in inflammatory breast cancer: a survival analysis of 3500 patientsResponse to Letter to the Editor: "The impact of chemotherapy sequence on survival in node-positive invasive lobular carcinoma"
P50
Q33842235-910A2218-C7DB-4A4C-AC81-EA53965E9C4AQ34053848-F2B0D844-89D0-464B-A2FE-A5E068CF3396Q35192288-2D262928-AB86-479A-88A9-1D984CEDD1F3Q35907408-C2D9D611-F314-4A53-85C2-5E59C4F9378DQ36934298-A3A89284-A06E-4196-9A76-25E1C0A31F94Q37000429-815B8239-DDEC-449F-BB98-705FF72C07B5Q37208198-3A4BE10B-1E40-454D-A3FC-FF3DE39EAAAFQ37579558-77EBAA65-F34E-4A7A-BA2D-3391F23A94B4Q37696698-8A2D9638-3C90-4C3A-A48C-205DC9698C2DQ38647499-403C56D6-AECA-4413-B40D-2F44A583245DQ38788573-4E9766F9-8349-450E-AE5D-1C635EEC809CQ39442392-D9563771-B655-4B9A-80FF-B03E3577E494Q39919074-7853365E-20CF-405D-8E8B-EE193CF89A4FQ47425155-ACA54F93-73A3-46C6-AD74-01517396E963Q48023842-DAC7E94D-1B75-4AE4-9D2F-0FEEA5F42BA7Q49843589-2880E1CE-8689-4A8D-AAC8-42D369E10F93Q88946200-37301F65-90E8-48F3-B3C5-F570A5A7345EQ89179946-7A7A338B-5849-4D1B-A1F2-4F0100AE86ABQ89398597-9E8512C1-1B1B-4BCA-B6C3-2A7C6958A8DFQ90644565-141CC447-C410-479A-9961-8DCAF65E419FQ91069835-AFC5CEDC-617B-4529-AC53-7A9F7F13B5F6Q91339009-2FE4B99D-0999-4936-B295-DE7209045F61Q91812936-6CF57FF2-740A-4924-B6BB-CB9E4229E3B0Q91844108-9D67B50F-7C62-4A28-A84A-47AF9C120D42Q92161970-CC0BC334-ED3D-4C45-B99F-B2AB87B76CA6Q92162150-6CBE5913-E3A8-46BE-A128-C45E146FEBF1Q92238715-FC23D3E5-0C2F-44FC-A72D-D8EC4304D62BQ92786372-E7BF6C14-CD54-4F05-9392-354EF2100106Q93007217-91034205-2364-4CA4-BE7E-D7303975D37A
P50
description
researcher ORCID ID = 0000-0002-0876-975X
@en
wetenschapper
@nl
name
Oluwadamilola M Fayanju
@ast
Oluwadamilola M Fayanju
@en
Oluwadamilola M Fayanju
@es
Oluwadamilola M Fayanju
@nl
type
label
Oluwadamilola M Fayanju
@ast
Oluwadamilola M Fayanju
@en
Oluwadamilola M Fayanju
@es
Oluwadamilola M Fayanju
@nl
prefLabel
Oluwadamilola M Fayanju
@ast
Oluwadamilola M Fayanju
@en
Oluwadamilola M Fayanju
@es
Oluwadamilola M Fayanju
@nl
P106
P1153
21233640600
P31
P496
0000-0002-0876-975X